Skip to main content
Erschienen in: Digestive Diseases and Sciences 8/2020

16.11.2019 | Original Article

Ninety-Six Hour Wireless Esophageal pH Study in Patients with GERD Shows that Restrictive Diet Reduces Esophageal Acid Exposure

verfasst von: George Triadafilopoulos, Julia Wilhelmina Korzilius, Thomas Zikos, Irene Sonu, Nielsen Q. Fernandez-Becker, Linda Nguyen, John O. Clarke

Erschienen in: Digestive Diseases and Sciences | Ausgabe 8/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Prolonged (96 h) pH monitoring may explore the effect of diet on pH and symptoms in patients with GERD.

Aims

To assess the usefulness of a 96 h esophageal pH study in patients with GER symptoms under different diets (pro- and anti-GER).

Methods

Prospective study of 66 patients with GERD undergoing wireless 96 h pH monitoring. Two-day periods, one on liberal (pro-reflux) and another on restricted (anti-reflux) diet assessed esophageal acid exposure and symptoms. The primary end point was normalization of acid exposure time while on restricted diet. Secondary end point was a > 50% reduction in symptoms with restricted diet.

Results

Normal (pH time < 4 of < 6%) was found in 34 patients (51.5%) while on the initial 48 h (liberal) diet [median % time < 4: 3.2 (95% CI, 1.9, 4.0)] and remained normal while on restricted diet [median % time < 4: 2.6 (95% CI, 0.8, 3.4)]. Abnormal acid exposure (% pH time < 4: > 6%) was found in 32 patients (48.5%) while on initial 48 h liberal diet [median % time < 4: 10.5, (95% CI 8.9, 12.6)], and decreased significantly with restricted diet [median % time < 4: 4.5 (95% CI 3.1, 7.3)] (p = 0.001), and normalized with anti-GERD diet in 21 patients (65.6%). Only 11/66 patients were candidates for proton pump inhibitor (PPI) use; 34 had either normal pH studies or normalized them with restricted diet (n = 21). Symptoms did not improve with restricted diet.

Conclusions

The 96-h esophageal pH study tests for GERD under pro- and anti-GER diets and allows minimization of PPI therapy to only 16.6% of patients.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Gyawali CP, de Bortoli N, Clarke J, et al. Indications and interpretation of esophageal function testing. Ann N Y Acad Sci. 2018;1434:239–253.CrossRef Gyawali CP, de Bortoli N, Clarke J, et al. Indications and interpretation of esophageal function testing. Ann N Y Acad Sci. 2018;1434:239–253.CrossRef
2.
Zurück zum Zitat Gyawali CP, Kahrilas PJ, Savarino E, et al. Modern diagnosis of GERD: the Lyon Consensus. Gut. 2018;67:1351–1362.CrossRef Gyawali CP, Kahrilas PJ, Savarino E, et al. Modern diagnosis of GERD: the Lyon Consensus. Gut. 2018;67:1351–1362.CrossRef
3.
Zurück zum Zitat Hirano I, Richter JE. Practice parameters Committee of the American College of Gastroenterology. ACG practice guidelines: esophageal reflux testing. Am J Gastroenterol. 2007;102:668–685.CrossRef Hirano I, Richter JE. Practice parameters Committee of the American College of Gastroenterology. ACG practice guidelines: esophageal reflux testing. Am J Gastroenterol. 2007;102:668–685.CrossRef
4.
Zurück zum Zitat Gaddam S, Sathyamurthy A, Kushnir V, et al. Changes in symptom reflux association using dynamic pH thresholds during ambulatory pH monitoring: an observational cross-sectional study. Dis Esophagus. 2016;29:1013–1019.CrossRef Gaddam S, Sathyamurthy A, Kushnir V, et al. Changes in symptom reflux association using dynamic pH thresholds during ambulatory pH monitoring: an observational cross-sectional study. Dis Esophagus. 2016;29:1013–1019.CrossRef
5.
Zurück zum Zitat Capovilla G, Salvador R, Spadotto L, et al. Long-term wireless pH monitoring of the distal esophagus: prolonging the test beyond 48 hours is unnecessary and may be misleading. Dis Esophagus. 2017;10:1–8.CrossRef Capovilla G, Salvador R, Spadotto L, et al. Long-term wireless pH monitoring of the distal esophagus: prolonging the test beyond 48 hours is unnecessary and may be misleading. Dis Esophagus. 2017;10:1–8.CrossRef
6.
Zurück zum Zitat Yamasaki T, O’Neil J, Fass R. Update on Functional Heartburn. Gastroenterol Hepatol (N Y).. 2017;13:725–734. Yamasaki T, O’Neil J, Fass R. Update on Functional Heartburn. Gastroenterol Hepatol (N Y).. 2017;13:725–734.
7.
Zurück zum Zitat Galindo G, Vassalle J, Marcus SN, et al. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy. Dis Esophagus. 2013;26:443–450.CrossRef Galindo G, Vassalle J, Marcus SN, et al. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy. Dis Esophagus. 2013;26:443–450.CrossRef
8.
Zurück zum Zitat Milkes D, Gerson LB, Triadafilopoulos G. Complete elimination of reflux symptoms does not guarantee normalization of intra-esophageal and intra-gastric pH in patients with gastroesophageal reflux disease (GERD). Am J Gastroenterol. 2004;99:991–996.CrossRef Milkes D, Gerson LB, Triadafilopoulos G. Complete elimination of reflux symptoms does not guarantee normalization of intra-esophageal and intra-gastric pH in patients with gastroesophageal reflux disease (GERD). Am J Gastroenterol. 2004;99:991–996.CrossRef
9.
Zurück zum Zitat Jones R, Junghard O, Dent J, et al. Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther. 2009;30:1030–1038.CrossRef Jones R, Junghard O, Dent J, et al. Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther. 2009;30:1030–1038.CrossRef
10.
Zurück zum Zitat Sami SS, Ragunath K. The Los Angeles classification of gastroesophageal reflux disease. Video J Encycl GI Endosc. 2013;1:103–104.CrossRef Sami SS, Ragunath K. The Los Angeles classification of gastroesophageal reflux disease. Video J Encycl GI Endosc. 2013;1:103–104.CrossRef
11.
Zurück zum Zitat Austin GL, Thiny MT, Westman EC, et al. A very low-carbohydrate diet improves gastroesophageal reflux and its symptoms. Dig Dis Sci. 2006;51:1307–1312.CrossRef Austin GL, Thiny MT, Westman EC, et al. A very low-carbohydrate diet improves gastroesophageal reflux and its symptoms. Dig Dis Sci. 2006;51:1307–1312.CrossRef
12.
Zurück zum Zitat Kahrilas PJ, Bredenoord AJ, Fox M, Gyawali CP, et al. International high resolution manometry working group. The Chicago classification of esophageal motility disorders, v.30. Neurogastroenterol Motil. 2015;27:160–174.CrossRef Kahrilas PJ, Bredenoord AJ, Fox M, Gyawali CP, et al. International high resolution manometry working group. The Chicago classification of esophageal motility disorders, v.30. Neurogastroenterol Motil. 2015;27:160–174.CrossRef
13.
Zurück zum Zitat Dent J, El-Serag HB, Wallander MA. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005;54:710–717.CrossRef Dent J, El-Serag HB, Wallander MA. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005;54:710–717.CrossRef
14.
Zurück zum Zitat Klauser AG, Schindlbeck NE, Muller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet. 1990;335:205–208.CrossRef Klauser AG, Schindlbeck NE, Muller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet. 1990;335:205–208.CrossRef
15.
Zurück zum Zitat Kahrilas PJ, Pandolfino JE. Review article: oesophageal pH monitoring–technologies, interpretation and correlation with clinical outcomes. Aliment Pharmacol Ther. 2005;22:2–9.CrossRef Kahrilas PJ, Pandolfino JE. Review article: oesophageal pH monitoring–technologies, interpretation and correlation with clinical outcomes. Aliment Pharmacol Ther. 2005;22:2–9.CrossRef
16.
Zurück zum Zitat Penagini R, Sweis R, Mauro A, et al. Inconsistency in the diagnosis of functional heartburn: usefulness of prolonged wireless pH monitoring in patients with proton pump inhibitor refractory gastroesophageal reflux disease. J Neurogastroenterol Motil. 2015;21:265–272.CrossRef Penagini R, Sweis R, Mauro A, et al. Inconsistency in the diagnosis of functional heartburn: usefulness of prolonged wireless pH monitoring in patients with proton pump inhibitor refractory gastroesophageal reflux disease. J Neurogastroenterol Motil. 2015;21:265–272.CrossRef
17.
Zurück zum Zitat Kaltenbach T, Crockett S, Gerson LB. Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach. Arch Intern Med. 2006;166:965–971.CrossRef Kaltenbach T, Crockett S, Gerson LB. Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach. Arch Intern Med. 2006;166:965–971.CrossRef
18.
Zurück zum Zitat Gudzune KA, Doshi RS, Mehta AK, et al. Efficacy of commercial weight-loss programs: an updated systematic review. Ann Intern Med. 2015;162:501–512.CrossRef Gudzune KA, Doshi RS, Mehta AK, et al. Efficacy of commercial weight-loss programs: an updated systematic review. Ann Intern Med. 2015;162:501–512.CrossRef
19.
Zurück zum Zitat Triadafilopoulos G, Zikos T, Regalia K, et al. Use of esophageal pH monitoring to minimize proton-pump inhibitor utilization in patients with gastroesophageal reflux symptoms. Dig Dis Sci. 2018;63:2673–2680.CrossRef Triadafilopoulos G, Zikos T, Regalia K, et al. Use of esophageal pH monitoring to minimize proton-pump inhibitor utilization in patients with gastroesophageal reflux symptoms. Dig Dis Sci. 2018;63:2673–2680.CrossRef
Metadaten
Titel
Ninety-Six Hour Wireless Esophageal pH Study in Patients with GERD Shows that Restrictive Diet Reduces Esophageal Acid Exposure
verfasst von
George Triadafilopoulos
Julia Wilhelmina Korzilius
Thomas Zikos
Irene Sonu
Nielsen Q. Fernandez-Becker
Linda Nguyen
John O. Clarke
Publikationsdatum
16.11.2019
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 8/2020
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-019-05940-9

Weitere Artikel der Ausgabe 8/2020

Digestive Diseases and Sciences 8/2020 Zur Ausgabe

UNM CLINICAL CASE CONFERENCES

Liver Abscess: A Wolf in Sheep’s Clothing

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.